Herceptin is Indicated , as a single agent for treatment of HER2-overexpressing breast cancer in patients who have received one or more chemotherapy regimens for metastatic disease.
Category:
Trastuzumab Brand:
Roche Product Code:
Availability:
Available
Description
Herceptin is indicated for the treatment of adult patients with HER2 positive early breast cancer (EBC). - following surgery, chemotherapy